Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    January 2020
  1. CASANOVA MJ, Chaparro M, Gisbert JP
    Errors in the care of inflammatory bowel disease patients: "Errata" Study.
    Gastroenterol Hepatol. 2020 Jan 18. pii: S0210-5705(19)30260.
    PubMed     Text format     Abstract available


  2. ALONSO-ABREU I, Alarcon-Fernandez O, Carrillo-Palau M, Ramos-Lopez L, et al
    Survey of adherence to treatment in inflammatory bowel disease. ENADEII study.
    Gastroenterol Hepatol. 2020 Jan 13. pii: S0210-5705(19)30263.
    PubMed     Text format     Abstract available


    December 2019
  3. BOSCA MM, Alos R, Maroto N, Gisbert JP, et al
    Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease.
    Gastroenterol Hepatol. 2019 Dec 20. pii: S0210-5705(19)30259.
    PubMed     Text format     Abstract available


  4. GINARD D, Marin-Jimenez I, Barreiro-de Acosta M, Ricart E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis.
    Gastroenterol Hepatol. 2019 Dec 12. pii: S0210-5705(19)30256.
    PubMed     Text format     Abstract available


    November 2019
  5. SHENTOVA R, Baycheva M, Hadjiiski P, Kofinova D, et al
    Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis.
    Gastroenterol Hepatol. 2019 Nov 13. pii: S0210-5705(19)30220.
    PubMed     Text format     Abstract available


    October 2019
  6. BERMEJO F, Algaba A, Bonillo D, Jimenez L, et al
    Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps.
    Gastroenterol Hepatol. 2019 Oct 21. pii: S0210-5705(19)30198.
    PubMed     Text format     Abstract available


  7. MURZI M, Gordillo J, Oblitas E, Soriano G, et al
    Spontaneous hepatic portal venous gas in a patient with ulcerative colitis. A case report and a review.
    Gastroenterol Hepatol. 2019 Oct 19. pii: S0210-5705(19)30199.
    PubMed     Text format    


  8. HINOJOSA DEL VAL J, Barreiro-de Acosta M
    Questions and answers about the management of Crohn's disease and ulcerative colitis with vedolizumab.
    Gastroenterol Hepatol. 2019 Oct 18. pii: S0210-5705(19)30202.
    PubMed     Text format     Abstract available


  9. BARREIRO-DE ACOSTA M, Gutierrez A, Rodriguez-Lago I, Espin E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.
    Gastroenterol Hepatol. 2019 Oct 9. pii: S0210-5705(19)30195.
    PubMed     Text format     Abstract available


    September 2019
  10. VELAYOS JIMENEZ B, Cuello Garcia R, Del Olmo Martinez L, Macho Conesa A, et al
    Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab.
    Gastroenterol Hepatol. 2019 Sep 2. pii: S0210-5705(19)30168.
    PubMed     Text format    


    August 2019
  11. OLMEDO-MARTIN RV, Gonzalez-Molero I, Olveira G, Amo-Trillo V, et al
    Sunlight exposure in inflammatory bowel disease outpatients: Predictive factors and correlation with serum vitaminD.
    Gastroenterol Hepatol. 2019 Aug 28. pii: S0210-5705(19)30167.
    PubMed     Text format     Abstract available


  12. RODRIGUEZ-LAGO I, Merino O, Lopez de Goicoechea MJ, Aranzamendi M, et al
    Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.
    Gastroenterol Hepatol. 2019 Aug 8. pii: S0210-5705(19)30159.
    PubMed     Text format     Abstract available


  13. PENA-VELEZ R, Almanza-Miranda E, Zaragoza-Arevalo GR
    Crohn's disease in a girl with VACTERL association: Can mitochondrial dysfunction coexist?
    Gastroenterol Hepatol. 2019;42:435-436.
    PubMed     Text format    


    June 2019
  14. FERRER BRADLEY I, Maroto Arce N, Mora Escrig M, Hinojosa Del Val J, et al
    Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy.
    Gastroenterol Hepatol. 2019;42:387-388.
    PubMed     Text format    


    May 2019
  15. CASAS DEZA D, Llorente Barrio M, Monzon Baez RM, Lamuela Calvo LJ, et al
    It is not always Crohn's disease: Amebiasis as a differential diagnosis of inflammatory bowel disease.
    Gastroenterol Hepatol. 2019 May 20. pii: S0210-5705(19)30100.
    PubMed     Text format    


  16. PANES J, Gisbert JP
    Efficacy of tofacitinib treatment in ulcerative colitis.
    Gastroenterol Hepatol. 2019 May 14. pii: S0210-5705(19)30094.
    PubMed     Text format     Abstract available


    April 2019
  17. SEDANO MUNOZ R, Quera Pino R, Ibanez Lazo P, Figueroa Corona C, et al
    Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
    Gastroenterol Hepatol. 2019 Apr 3. pii: S0210-5705(19)30056.
    PubMed     Text format     Abstract available


  18. NUNEZ F P, Quera P R, Gomollon F
    Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation.
    Gastroenterol Hepatol. 2019 Apr 1. pii: S0210-5705(19)30055.
    PubMed     Text format     Abstract available


  19. FRASER CG
    Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies.
    Gastroenterol Hepatol. 2019;42:263-270.
    PubMed     Text format     Abstract available


    March 2019
  20. NAVARRO B, Blazquez T, Herreras J, Iborra M, et al
    Acute myocardial infarction in a patient with a recent diagnosis of Crohn's disease.
    Gastroenterol Hepatol. 2019;42:183-184.
    PubMed     Text format    


  21. GONZALEZ-OLIVARES C, Palomera-Rico A, Romera-Pintor Blanca N, Sanchez-Aldehuelo R, et al
    Pneumatosis intestinalis in Crohn's disease.
    Gastroenterol Hepatol. 2019;42:181-183.
    PubMed     Text format    


    February 2019
  22. RIOS LEON R, Jaureguizar Oriol A, Lopez-Sanroman A, Jimenez Castro D, et al
    Acute severe pulmonary toxicity due to biosimilar infliximab in a Crohn's disease patient.
    Gastroenterol Hepatol. 2019;42:104-105.
    PubMed     Text format    


    January 2019
  23. HERNANZ N, Sierra M, Volpato N, Nunez-Gomez L, et al
    Autologous haematopoietic stem cell transplantation in refractory Crohn's disease: Experience in our centre.
    Gastroenterol Hepatol. 2019;42:16-22.
    PubMed     Text format     Abstract available


  24. SILVA M, Rios E, Peixoto A, Macedo G, et al
    Intestinal pseudopolyps in a patient with Crohn's disease and renal transplant - An unexpected diagnosis.
    Gastroenterol Hepatol. 2019;42:32-33.
    PubMed     Text format    


  25. GARCIA-MORALES N, Garcia-Campos M, Cordon G, Iborra M, et al
    Intestinal tuberculosis simulating Crohn's disease: Differential diagnosis.
    Gastroenterol Hepatol. 2019;42:29-32.
    PubMed     Text format    


  26. BRUNET E, Martinez de Sola M, Garcia-Iglesias P, Calvet X, et al
    Immune thrombocytopenic purpura associated with Crohn's disease with complete response to infliximab.
    Gastroenterol Hepatol. 2019;42:37-38.
    PubMed     Text format    


    December 2018
  27. SEDANO MUNOZ R, Quera Pino R, Lubascher Correa J, Pizarro Jofre G, et al
    Evaluation of de-escalation of anti-TNF-alpha therapy in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Dec 27. pii: S0210-5705(18)30317.
    PubMed     Text format     Abstract available


    November 2018
  28. LLORENTE BARRIO M, Garcia Lopez S, Gilaberte Calzada Y, Monzon Baez RM, et al
    Bilateral pyoderma gangrenosum associated with ulcerative colitis and restorative proctocolectomy.
    Gastroenterol Hepatol. 2018 Nov 20. pii: S0210-5705(18)30285.
    PubMed     Text format    


    October 2018
  29. RODRIGUEZ-LAGO I, Ferreiro-Iglesias R, Nos P, Gisbert JP, et al
    Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey.
    Gastroenterol Hepatol. 2018 Oct 4. pii: S0210-5705(18)30251.
    PubMed     Text format     Abstract available


  30. GUARDIOLA J, Lobaton T, Cerrillo E, Ferreiro-Iglesias R, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018;41:514-529.
    PubMed     Text format     Abstract available


    August 2018
  31. SANCHEZ RODRIGUEZ E, Rios Leon R, Mesonero Gismero F, Albillos A, et al
    Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Aug 11. pii: S0210-5705(18)30205.
    PubMed     Text format     Abstract available


  32. LOPEZ-SANROMAN A, Clofent J, Garcia-Planella E, Menchen L, et al
    Reviewing the therapeutic role of budesonide in Crohn's disease.
    Gastroenterol Hepatol. 2018;41:458-471.
    PubMed     Text format     Abstract available


    July 2018
  33. NUNEZ-GOMEZ L, Mesonero-Gismero F, Albillos-Martinez A, Lopez-Sanroman A, et al
    Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease.
    Gastroenterol Hepatol. 2018 Jul 24. pii: S0210-5705(18)30195.
    PubMed     Text format     Abstract available


  34. IBORRA M, Beltran B, Maroto N, Navarro-Cortes P, et al
    Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
    Gastroenterol Hepatol. 2018 Jul 18. pii: S0210-5705(18)30186.
    PubMed     Text format     Abstract available


  35. MIRANDA-BAUTISTA J, Menchen L
    Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.
    Gastroenterol Hepatol. 2018 Jul 17. pii: S0210-5705(18)30191.
    PubMed     Text format    


    June 2018
  36. YAMAMOTO-FURUSHO JK, Sarmiento-Aguilar A, Garcia-Alanis M, Gomez-Garcia LE, et al
    Hospital Anxiety and Depression Scale (HADS): Validation in Mexican Patients with Inflammatory Bowel Disease.
    Gastroenterol Hepatol. 2018 Jun 21. pii: S0210-5705(18)30138.
    PubMed     Text format     Abstract available


    May 2018
  37. GISBERT JP, Chaparro M
    Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review.
    Gastroenterol Hepatol. 2018 May 9. pii: S0210-5705(18)30108.
    PubMed     Text format     Abstract available


  38. RODRIGUEZ-LAGO I, Benitez JM, Garcia-Sanchez V, Gutierrez A, et al
    Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.
    Gastroenterol Hepatol. 2018 May 5. pii: S0210-5705(18)30110.
    PubMed     Text format     Abstract available


    April 2018
  39. SUAREZ FERRER C, Poza Cordon J, Cerpa Arencibia A, Sanchez Azofra M, et al
    Perspectiva actual hospitalization in inflammatory bowel disease: Current perspective.
    Gastroenterol Hepatol. 2018 Apr 7. pii: S0210-5705(18)30034.
    PubMed     Text format    


    March 2018
  40. FRAILE LOPEZ M, de Francisco R, Perez-Martinez I, Garcia Garcia B, et al
    Pyoderma gangrenosum and primary cutaneous cryptococcosis in an ulcerative colitis patient.
    Gastroenterol Hepatol. 2018 Mar 5. pii: S0210-5705(18)30050.
    PubMed     Text format    


    February 2018
  41. GOBBO M, Carmona L, Panadero A, Canas M, et al
    The psychosocial impact of inflammatory bowel disease and its management. From the patients' perspective.
    Gastroenterol Hepatol. 2018 Feb 5. pii: S0210-5705(18)30006.
    PubMed     Text format    


  42. MERINO RODRIGUEZ E, Carrera Alonso E, Torralba Gonzalez de Suso M, Sanchez da Silva M, et al
    Ionizing diagnostic radiation exposure in patients with Crohn's disease: A retrospective study in a medium hospital and its predictive factors.
    Gastroenterol Hepatol. 2018;41:97-102.
    PubMed     Text format     Abstract available


    January 2018
  43. BERMEJO F, Aguas M, Chaparro M, Domenech E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of tiopurines in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Jan 18. pii: S0210-5705(17)30248.
    PubMed     Text format     Abstract available


    December 2017
  44. BARREIRO-DE ACOSTA M, Marin-Jimenez I, Panadero A, Guardiola J, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease pa
    Gastroenterol Hepatol. 2017 Dec 20. pii: S0210-5705(17)30244.
    PubMed     Text format     Abstract available


  45. DE LA PISCINA PR, Delgado E, Duca I, Estrada S, et al
    Acute infection due to Mycobacterium marinum in a patient with ulcerative colitis and metabolic syndrome on infliximab therapy.
    Gastroenterol Hepatol. 2017 Dec 16. pii: S0210-5705(17)30241.
    PubMed     Text format    


    September 2017
  46. GONZALEZ ALAYON C, Pedrajas Crespo C, Marin Pedrosa S, Benitez JM, et al
    Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life.
    Gastroenterol Hepatol. 2017 Sep 9. pii: S0210-5705(17)30189.
    PubMed     Text format     Abstract available


  47. SANZ SANZ J, Juanola Roura X, Seoane-Mato D, Montoro M, et al
    Screening of Inflammatory Bowel Disease and Spondyloarthritis for Referring Patients Between Rheumatology and Gastroenterology.
    Gastroenterol Hepatol. 2017 Sep 4. pii: S0210-5705(17)30184.
    PubMed     Text format     Abstract available


    August 2017
  48. GUERRERO PUENTE L, Iglesias Flores E, Benitez JM, Medina Medina R, et al
    Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.
    Gastroenterol Hepatol. 2017 Aug 30. pii: S0210-5705(17)30182.
    PubMed     Text format     Abstract available


  49. AGUAS M, Del Hoyo J, Faubel R, Valdivieso B, et al
    Telemedicine in the treatment of patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Aug 7. pii: S0210-5705(17)30166.
    PubMed     Text format     Abstract available


    July 2017
  50. TORRES P, Lobaton T, Canete F, Clos A, et al
    Cytomegalovirus primoinfection in inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Jul 19. pii: S0210-5705(17)30161.
    PubMed     Text format    


    June 2017
  51. AGUD FERNANDEZ M, Lopez Lopez F, Diaz Pedroche C, Gomez-Martin C, et al
    Concurrent inflammatory bowel disease and gastrointestinal stromal tumor.
    Gastroenterol Hepatol. 2017 Jun 24. pii: S0210-5705(17)30136.
    PubMed     Text format    


  52. DOMENECH E, Lopez-Sanroman A, Nos P, Vera M, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn's disease.
    Gastroenterol Hepatol. 2017 Jun 9. pii: S0210-5705(17)30126.
    PubMed     Text format     Abstract available


    February 2017
  53. SEBASTIAN DOMINGO JJ
    Review of the role of probiotics in gastrointestinal diseases in adults.
    Gastroenterol Hepatol. 2017 Feb 6. pii: S0210-5705(17)30003.
    PubMed     Text format     Abstract available


    December 2016
  54. MONTESERIN L, Jimenez M, Molina G, Reyes N, et al
    Colonic pseudopolyposis in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Dec 21. pii: S0210-5705(16)30161.
    PubMed     Text format    


    September 2016
  55. GARCIA-LOPEZ S
    Inflammatory bowel disease in Digestive Disease Week 2016: advances in epidemiology, follow-up, treatment monitoring, optimisation and individual tailoring, and colon cancer prevention.
    Gastroenterol Hepatol. 2016;39 Suppl 1:29-35.
    PubMed     Text format     Abstract available


  56. CHAPARRO M
    Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016.
    Gastroenterol Hepatol. 2016;39 Suppl 1:20-28.
    PubMed     Text format     Abstract available


  57. GOMOLLON F
    Treatment adherence is always worse than we think: an unresolved problem in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016;39 Suppl 1:14-19.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: